Featured Funding
Application Deadline: October 13, 2026 at 10AM
Bridge Project Request for Applications. Please note that there have been some eligibility changes that should be noted.
Collaborating Against Cancer
The Harvard Cancer Consortium brings together over 1,100 cancer researchers at seven institutions to collaborate, coordinate, and innovate in the fight against cancer.
Image Credit: The lab of William Hahn, MD, PhD; Researcher Lior Roitman, PhD(opens in new window)
Featured Event
Event Date: September 29, 2026
Location: Virtual
Please join us for the launch of the HCC Core Spotlight Series with the Spatial Technologies Unit (STU)!
Consider Becoming an HCC Member
HCC membership grants access to Center-sponsored core facilities at a reduced rate, clinical research support for protocol management, and members-only developmental funding opportunities.
Our strength is in our numbers.
Harvard Cancer Consortium (HCC), an NCI-designated comprehensive cancer center, was founded to integrate and build upon the collective talent and resources of the Harvard cancer research community.
Beth Israel Deaconess Medical Center(opens in new window)
Boston Children's Hospital(opens in new window)
Brigham and Women's Hospital(opens in new window)
Dana-Farber Cancer Institute(opens in new window)
Harvard Medical School(opens in new window)
Harvard T.H. Chan School of Public Health(opens in new window)- Massachusetts General Hospital(opens in new window)
With HCC Pathfinder, great opportunities and helpful resources have never been easier to find.
Discover upcoming opportunities for funding, learning, meetings, and events. Or explore Pathfinder’s Toolbox, a new, curated collection of essential funding application resources.